摘要:
The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 denotes a group A selected from among —O—R3, —NR3R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3 and SO2—R3 or R1 denotes a group B selected from among C6-10-aryl, five- to ten-membered, mono- or bicyclic heteroaryl with 1-3 heteroatoms selected independently of one another from among N, O and S; while this heteroaryl is linked to the structure according to formula 1 via either a C atom or an N atom, three- to ten-membered, mono- or bicyclic, saturated or partially saturated heterocyclic group with 1-3 heteroatoms selected independently of one another from among N, O and S, while this heterocyclic group is linked to the structure according to formula 1 via either a C atom or an N atom, and 5- to 11-membered spiro group which may optionally contain 1, 2 or 3 heteroatoms selected independently of one another from among N, O and S, while this spiro group is linked to the structure according to formula 1 via either a C atom or an N atom, while this group B may optionally be substituted as described in claim 1 and wherein R2 is and R3, R4, R5, R6, R6′, R7, R8, R9, R10, V, n and m may have the meanings given in claim 1, as well as pharmaceutical compositions containing these compounds.
摘要:
The invention relates to novel substituted naphthyridines of formula 1 as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof. In formula 1, R1 can represent a group A selected from among the group comprising —O—R3, —NR3 R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3, and SO2—R3, or R1 represents a group B selected from among the group comprising: —C6-10-aryl;—a five-membered to ten-membered, monocyclic or bicyclic heteroaryl containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heteroaryl is linked to the structure according to formula 1 via a C atom or an N atom;—a three-membered to ten-membered, monocyclic or bicyclic, saturated or partially saturated heterocycle containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heterocycle is linked to the structure according to formula 1 via a C atom or an N atom; and—a 5-membered to 11-membered spiro group which can optionally contain 1, 2, or 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said spiro group is linked to the structure according to formula 1 via a C atom or an N atom, wherein said group B can be optionally substituted as described in claims 1, and R3,R4,R5,R6, and m can have the meanings indicated in claim 1. The invention also relates to pharmaceutical compositions containing said compounds.
摘要:
The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 and R6 may have the meanings as described in claim 1, as well as medicaments which contain these compounds. Further, the invention relates to methods of treating a disease selected from asthma, COPD, allergic rhinitis, adult respiratory distress syndrome, bronchitis, allergic dermatitis, contact dermatitis, idiopathic thrombocytopenic purpura, rheumatoid arthritis and allergic rhinoconjunctivitis by administrating an appropriate amount of a compound of formula 1 to a patient in need thereof.
摘要:
The invention relates to novel substituted naphthyridines of formula 1 as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof. In formula 1, R1 can represent a group A selected from among the group comprising —O—R3, —NR3R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3, and SO2—R3, or R1 represents a group B selected from among the group comprising: —C6-10-aryl; —a five-membered to ten-membered, monocyclic or bicyclic heteroaryl containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heteroaryl is linked to the structure according to formula 1 via a C atom or an N atom; —a three-membered to ten-membered, monocyclic or bicyclic, saturated or partially saturated heterocycle containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heterocycle is linked to the structure according to formula 1 via a C atom or an N atom; and —a 5-membered to 11-membered spiro group which can optionally contain 1, 2, or 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said spiro group is linked to the structure according to formula 1 via a C atom or an N atom, wherein said group B can be optionally substituted as described in claims 1, and R3, R4, R5, R6, and m can have the meanings indicated in claim 1. The invention also relates to pharmaceutical compositions containing said compounds.
摘要翻译:本发明涉及式1的新型取代萘啶以及其药理学上可接受的盐,非对映异构体,对映异构体,外消旋物,水合物或溶剂合物。 在式1中,R 1可以表示选自-O-R 3,-NR 3 R 4,-CR 3 R 4 R 5, - (乙炔)-R 3,-S-R 3,-SO-R 3和SO 2 -R 3的基团A,或 R 1表示选自以下的基团B:-C 6-10 - 芳基; 包含1至3个独立地选自N,O和S的杂原子的五元至十元单环或二环杂芳基,其中所述杂芳基通过C原子连接至根据式1的结构,或 一个N原子; 包含1-3个独立地选自包括N,O和S的杂原子的3至10元,单环或双环饱和或部分饱和的杂环,其中所述杂环与根据式1的结构连接 通过C原子或N原子; 和可以任选地含有1,2或3个独立地选自N,O和S的组的杂原子的5元至11元螺环,其中所述螺环与根据式1的结构连接 通过C原子或N原子,其中所述基团B可以如权利要求1所述任选被取代,并且R 3,R 4,R 5,R 6和m可以具有权利要求1中所示的含义。本发明还涉及药物组合物 含有所述化合物。
摘要:
An opening/closing detection unit detects a transition of an electronic device from an open state to a closed state or from the closed state to the open state. An electrical-power control unit sets an operation mode of an application processing unit that executes an application. When a transition from the open state to the closed state is detected while a hold switch is in an OFF state, the electrical-power control unit switches an operation mode of an application processing unit from a normal mode to a sleep mode. On the other hand, when a transition from the open state to the closed state is detected while the hold switch is in an ON state, the electrical-power control unit does not switch the operation mode of the application processing unit from the normal mode to the sleep mode.
摘要:
A firmware verification section verifies whether a firmware for controlling the activating of contents has been falsified or not, prior to the activating of the contents; a decoding key setting section sets a key to the firmware; the key is used to decode an encrypted activation program for activating the contents, when the firmware has not been falsified; and an activation program decoding section decodes the encrypted activation program by using the firmware with the key set to the firmware.
摘要:
A liquid container which supplies ink to its exterior until the ink is almost depleted and allows simple detection of the remaining ink amount, is constructed to distribute components of the ink even after a prolonged standing. The liquid container is provided with a connecting portion for connection to an ink deriving tube and an air introduction tube of an ink jet printer. Both the ink deriving tube and the air introduction tube are positioned for connection to the connecting portion at a position deviated from a center of the bottom of the liquid container. The deviation facilitates mixing of ink components as ink is supplied from the container.
摘要:
A method for manufacturing an electrode comprising the steps of: applying onto a substrate a conductive paste to form a conductive paste layer comprising; (i) 100 parts by weight of a copper powder coated with a metal oxide selected from the group consisting of silicon oxide (SiO2), zinc oxide (ZnO), aluminum oxide (Al2O3), titanium oxide (TiO2), magnesium oxide (MgO) and a mixture thereof; (ii) 5 to 30 parts by weight of a boron powder; and (iii) 0.1 to 10 parts by weight of a glass frit; dispersed in (iv) an organic vehicle; and firing the conductive paste in air.
摘要:
An opening/closing detection unit detects a transition of an electronic device from an open state to a closed state or from the closed state to the open state. An electrical-power control unit sets an operation mode of an application processing unit that executes an application. When a transition from the open state to the closed state is detected while a hold switch is in an OFF state, the electrical-power control unit switches an operation mode of an application processing unit from a normal mode to a sleep mode. On the other hand, when a transition from the open state to the closed state is detected while the hold switch is in an ON state, the electrical-power control unit does not switch the operation mode of the application processing unit from the normal mode to the sleep mode.
摘要:
An LSI system includes; a multi-layer print board; and a plurality of LSI circuit chips mounted on the multi-layer printed circuit board, each including a plurality of pins, a reference voltage terminal, a pin scan out terminal and a plurality of pin scan out circuits corresponding to the pins on a one-to-one basis. The multi-layer printed circuit board includes a reference voltage feeding layer formed therein in a form of a mesh or a sheet, at least one further layer overlying the reference voltage feeding layer and a plurality of through holes extending through each such further layer. By electrically connecting each reference voltage terminal of the plurality of LSI circuit chips through a corresponding through hole to the reference voltage feeding layer, a substantially equal reference voltage can be fed to each LSI and the voltage drop thereof is reduced.